ARTICLE | Company News
Faulk Pharmaceuticals, Panther Biotechnology deal
August 24, 2015 7:00 AM UTC
Panther completed the acquisition of Faulk’s pharmaceutical assets for 50,000 Panther shares. The shares are valued at $299,500 based on Panther’s close of $5.99 on July 15, before the deal closed. Pa...